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Aim: The aim of this work was to evaluate the efﬁcacy of exercise training program as a type of
physical therapy approach in treatment of sarcopenic obesity and dyslipidemia after liver
transplantation.
Subjects and methods: Thirty patients with liver transplantation since six months had
participated in this study. The patients were randomly divided into two groups of equal numbers.
The exercise group received aerobic and resisted exercise in addition to receive the traditional
medical intervention. The control group received only the traditional medical intervention.
Measurements of fat mass, muscle mass, cholesterol level and triglycerides level (by bioelectrical
impedance and lipid proﬁle) were collected before treatment and after three months of treatment.
Results: Comparison between exercise and control groups post treatment revealed a signiﬁcant
decrease in fat mass, cholesterol and triglyceride levels in the exercise group compared to the control
group (p< 0.001), while there was a signiﬁcant increase in muscle mass in the exercise group com-
paired to control group (p= 0.0001).
Conclusion: Aerobic and resisted exercise has a positive effect in treatment of sarcopenic obesity
and dyslipidemia (reducing fat mass, cholesterol and triglycerides levels while increasing muscle
mass) post liver transplantation.
 2015 Production and hosting by Elsevier B.V. on behalf of Ain Shams University.1. Introduction
Malnutrition and impaired body composition with loss of total
body protein are characteristic ﬁndings in patients with end-
stage chronic liver disease [1]. Liver transplantation LT is the
only therapy that halts the progression of the disease [2].
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greatly in the last decade, the combination of transplantation
with immunosuppressant medication is still associated with
several comorbidities, including dyslipidemia, hypertension,
diabetes, obesity, osteoporosis, sarcopenia, muscle pain, and
metabolic syndrome [2]. Physical function is also limited in
patients who underwent a liver transplantation [3,4]and associ-
ations between poor prognosis and reduced physical function
have been reported [3,5].
Obesity [body mass index (BMI) > 30 kg/m2] develops in
21–43% of patients post-LT. The prevalence of dyslipidemia
post-LT ranges from 66% to 85%. An increase in the preva-
lence of dyslipidemia from 8% before LT to 66% after LT.
Elevated cholesterol and hypertriglyceridemia developed in
19% and 59%, respectively [6]. Another study reported an
increase in the prevalence of both elevated total cholesterol
(2.9% pre-LT versus post-LT 15.3%) and triglycerides
(18.2% pre-LT versus post-LT 70%) at 6 months post-trans-
plant [7].
Long-term survivors of liver transplant are not only
overweight but exhibit an abnormal body composition charac-
terized by an excess of body fat and obesity and a deﬁcit in
skeletal muscle mass, i.e., sarcopenia. This pattern closely
resembles that of sarcopenic obesity in cancer or elderly
patients [8].
The etiology of dyslipidemia involves many factors, though
the immunosuppressive agents are the main triggering factor.
Steroids are associated with hyperlipidemia as they stimulate
the activity of acetyl-CoA carboxylase and the synthesis of
fatty acids, thus raising concentrations of total cholesterol
and triglycerides [9]. M-TOR inhibitors increase lipoprotein-
lipase activity, increasing the hepatic synthesis of triglycerides
[10]. Calcineurin inhibitors reduce the excretion of cholesterol
to the bile and the peripheral LDL-cholesterol receptors,
thereby raising circulating levels of cholesterol [11].
The link between exercise and improved physical condition
has been well established in patients after different types of
transplantation [12]. Exercise training can improve exercise
capacity, body composition, and muscle strength following
different types of transplantation [13–15]. Aerobic exercise
promotes beneﬁcial changes in whole-body metabolism and
reduces fat mass, while resistance exercise preserves lean (mus-
cle) mass [16]. While resistance training such as weight lifting
increases myoﬁbrillar muscle protein synthesis [17], muscle
mass and strength [18].
Aerobic exercise increases insulin sensitivity independent of
weight loss, inhibits hepatic lipid synthesis and stimulates fatty
acid oxidation [19]. Also exercise increases fatty acid oxidation
from adipose, intramyocellular, and possibly hepatic sources.
Speciﬁcally, there is a signiﬁcant increase during and after
exercise in both very low density lipoprotein (VLDL) secretion
and VLDL clearance by skeletal muscle, which may accelerate
the removal of hepatic triglyceride concentration derived fatty
acids. The capacity for VLDL clearance is also known to
improve with regular exercise training [20].
2. Subjects and methods
Thirty volunteer patients from the El Sahel Teaching Hospital
who had liver transplantation since six months were included
in the study from February 2013 to September 2014. Their
ages ranged from 45 to 55 years. They were examined carefullyby the physician before the study procedures. The patients
were excluded if they had cancer or were currently being
treated for cancer of any origin, neurological or neuromuscu-
lar disorders, osteoarthritis or other orthopedic injury,
multiorgan transplant recipients, patients used a wheelchair
as their primary mode of mobility and any other cardiovascu-
lar contraindication to exercise testing and training [21].
2.1. Patients
The patients were randomly assigned into two main groups (A
and B). Group A: (exercise group) included 15 patients who
received the aerobic and resisted exercises in addition to tradi-
tional medical intervention. Group B: (Control group)
included 15 patients who had not received any form of physical
therapy intervention at any time during the study but this
group was instructed and encouraged to remain active and
received the traditional medical intervention.
2.2. Ethical consideration
The study protocol was explained in detail for each patient
before the initial assessment and signed informed consent
was obtained from each patient before enrollment in the study
as well as acceptance of the Ethics committee of the University.
The work has been carried out in accordance with The Code of
Ethics of the World Medical Association (Declaration of Hel-
sinki) for experiments involving humans.
2.3. Assessment
Before initiating the treatment program, primary clinical and
laboratory investigations were done (liver function tests, renal
function tests and blood levels of the antirejection medication)
to draw a complete picture of health for all patients and to
decide if the patient is able to participate in the study. Each
patient was examined medically in order to exclude any abnor-
mal medical problem which was previously mentioned. The
patient’s name, age, weight and height, were written in the
evaluation sheet of every patient. The assessment procedures
were conducted before treatment application and at the end
of the study after 3 months.
2.3.1. Assessment of BMI for each patient
Measuring weight and height of each patient by weight and
height scale, BMI was calculated according to the following
equation: BMI = weight (kg)/height (m2). BMI was calculated
before the study only to select the patients who had
BMI > 30 kg/m2 according to classiﬁcation of obesity to par-
ticipate in the study [22].
2.3.2. Body composition analyses
Different methods have been developed to measure body com-
position parameters. We used Bioelectrical Impedance Analy-
sis (BIA), which is an easy, quick, cost-effective and painless
test to determine body composition and ﬂuid status and has
been widely used in body composition analysis [23,24].
Fat mass and muscle mass were measured by using Bioelec-
trical Impedance Analysis (beurer BF 100_Body Complete,
made in Germany).
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the morning following an overnight fast and wearing light
indoor clothes. Patients were not allowed to drink during
fasting and were asked to empty their bladders before mea-
surements. The patients were asked to ﬁrst wipe the sole of
the feet by a wet tissue and then stand over the electrodes of
the machine and data were recorded in 3–5 min.
2.3.3. Laboratory assessment
Venous blood samples were collected in polystyrene tubes after
a 12 h fasting by venipuncture of the antecubital vein while
patients rested in a supine position for estimation of serum tri-
glycerides and cholesterol level.
2.3.4. Muscle strength testing (one-repetition maximum (1-
RM) testing)
Only the patients in the exercise group were tested to deter-
mine the amount of weight or load to use as baseline loads
in the ﬁrst week of the 12-week program. They were tested
in the following order of exercises: bench press, leg press,
shoulder press, leg extension, biceps curl, leg curl, and triceps
curl. The (1-RM) load was determined as follows. After a 30-
min rest, the participants lifted increasingly heavy weights, and
the maximal amount of weight that they could lift was
recorded as the 1-RM for each exercise [25]. Participants were
initially given instructions and shown how to perform the exer-
cises and then practiced during a trial session before the base-
line measurements. All exercise testing sessions were medically
supervised.
2.4. Therapeutic exercise program
All exercise sessions and exercise prescriptions were supervised
by a physical therapist and were conducted according to the
guidelines set by the American College of Sports Medicine
(ACSM) [26,27]. No strength training activities were permitted
outside the supervised training session; however, both groups
were allowed to pursue their normal daily activities. All
patients were sedentary before starting the exercise program.
The exercise-training sessions consisted of three 90-min ses-
sions per week. Each session preceded by a 10 min warm-up
on the treadmill at intensity of less than 50% of HR max
and stretching exercises for: quadriceps, hamstring and calf
muscles, 30 min of aerobic exercise, 30 min of progressive
resistance training (PRT), and end with cooling down on the
treadmill as intensity decreased gradually to resting heart rate.
The PRT program consisted of 8 basic resistive exercises:
bench press, leg press, shoulder press, leg extension, biceps
curl, leg curl, triceps curl, and toe raises. Initially, the weight-
lifting sessions consisted of two sets of each exercise using a
weight that allowed completion of six to eight repetitions of
each exercise at 65% of 1-RM with 60 s of rest between each
set. After 4 weeks, they progressed to three sets of 8–12 rep-
etitions performed at 85% of initial 1-RM [25,28]. Participants
tracked the amount of PRT by using a training log to docu-
ment the weight and the number of repetitions performed.
Measurements of 1-RM were repeated monthly so that work-
loads could be progressed for each participant.
The aerobic training on a treadmill either walking or run-
ning was based on heart rate, until the target heart rate was
reached, according to American College of Sport Medicineguidelines. The program was conducted using the maximal
heart rate index (HRmax) estimated by: 220-age. First
2 weeks = 60–70% of HRmax, 3rd to 12th weeks = 70–80%
of HRmax [29].
2.5. Data analysis
Descriptive statistics and t-test were conducted for comparison
of the mean age, weight, height, and BMI between both
groups. Mixed ANOVA was conducted to compare between
the pre and post treatment mean values of fat mass, muscle
mass, cholesterol, and triglyceride levels in each group and
between both groups. The level of signiﬁcance for all statistical
tests was set at p< 0.05. All statistical analyses were con-
ducted through SPSS (statistical package for social sciences,
version 19).
3. Results
3.1. Subject characteristics
There was no signiﬁcant difference between both groups in the
mean age, weight, height, and BMI (p> 0.05).Table 1.
3.2. Comparison between groups
There was no signiﬁcant difference between exercise and con-
trol groups in fat mass, muscle mass, cholesterol, and triglyc-
erides on pre-treatment levels (p> 0.05). Comparison
between exercise and control groups post treatment revealed
a signiﬁcant decrease in fat mass, cholesterol, and triglycerides
levels in the exercise group compared to control (p< 0.001),
while there was a signiﬁcant increase in muscle mass in the
exercise group compared to control (p= 0.0001). Table 2,
Figs. 1 and 2.
3.3. Comparison within the same group
3.3.1. Results of exercise group
There was a signiﬁcant decrease in fat mass, cholesterol, and
triglycerides levels and a signiﬁcant increase in muscle mass
post treatment in exercise group compared with pre treatment
(p= 0.0001). Table 3, Figs. 1 and 2.
3.3.2. Results of control group
There was no signiﬁcant difference in fat mass, muscle mass,
and cholesterol level between pre and post treatment in control
group (p> 0.05), while there was a signiﬁcant increase in tri-
glyceride level post treatment compared with pre treatment
(p= 0.02) Table 3, Figs. 1 and 2.4. Discussion
It can be assured that exercise training program (aerobic and
resisted exercise) as a type of physical therapy approach was
signiﬁcantly more effective in the treatment of sarcopenic obes-
ity and dyslipidemia (reducing fat mass, cholesterol and tri-
glycerides levels while increasing muscle mass) post liver
transplantation. Our results agree with Van et al. [30], who
Table 2 Comparison of fat mass, muscle mass, cholesterol level, and triglycerides level between exercise and control groups pre and
post treatment.
Exercise group Control group MD p-Value
x  SD x  SD
Pre treatment Fat mass (%) 35.18 ± 3.45 36.02 ± 3 0.84 0.48*
Muscle mass (%) 29.24 ± 3.48 28.64 ± 3.3 0.6 0.62*
Cholesterol (mg/dl) 289.06 ± 15.79 285.86 ± 16.42 3.2 0.59*
Triglycerides (mg/dl) 289.8 ± 10.37 285.93 ± 12.17 3.87 0.35*
Post treatment Fat mass (%) 31.83 ± 3.36 36.41 ± 3.3 4.58 0.001**
Muscle mass (%) 32.22 ± 2.9 28.3 ± 2.92 3.9 0.001**
Cholesterol (mg/dl) 262.2 ± 12.57 289.86 ± 17.84 27.66 0.0001**
Triglycerides (mg/dl) 261.66 ± 15.77 291 ± 11.38 29.34 0.0001**
x: Mean, SD: Standard deviation, MD: Mean difference, p-value: Probability value.
* Non signiﬁcant.
** Signiﬁcant.
Figure 2 Pre and post treatment mean values of cholesterol and
triglycerides (mg/dl) of exercise and control groups.
Table 1 t Test for comparison between control and study groups in mean age, weight, height, and BMI.
x  SD MD t- Value p-Value
Exercise group Control group
Age (years) 50.33 ± 2.87 51.2 ± 2.88 0.87 0.82 0.41*
Weight (kg) 93.46 ± 9.32 94.13 ± 11.39 0.67 0.17 0.86*
Height (cm) 166.06 ± 9.14 167.6 ± 9.91 1.54 0.44 0.66*
BMI (kg/cm2) 33.86 ± 1.75 51.2 ± 2.88 0.44 0.71 0.48*
x: Mean, SD: Standard deviation, MD: Mean difference, t-value: unpaired t value, p-value: Probability value.
* Non signiﬁcant.
Figure 1 Pre and post treatment mean values of fat and muscle
mass (%) of exercise and control groups.
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in a 12-week rehabilitation program. After the program,
participants were signiﬁcantly less fatigued, and body fat was
signiﬁcantly lower.
Similarly, Roi et al. [31], who performed exercises
consisting of 3 sessions per week of aerobic and strengthening
exercises for 1 year on 5 patients with liver transplantations.
Patients show a signiﬁcant decrease in body mass index
(t= 1.966; p< .05) and a maximum strength of knee exten-
sors (t= 2.933; p< .05) and elbow ﬂexors (t= 2.450;
p< .05). These results conﬁrm the positive effects of super-
vised physical exercise. Also, in a systemic review by Didsbury
et al. [32] he found that, there was a consistent reduction inpercentage body fat associated with exercise training compared
with standard care in liver transplant recipients.
Toma´s et al. [33] found that exercise improved body com-
position (lean mass and total body skeletal muscle mass),
weight, and walking capacity in patients with LT. The
improvements were more pronounced within the patients with
supervised exercise training compared with the patients on the
home-based program. In general, the beneﬁts of the exercise
training persist even after a 24-week detraining period.
According to, Donges et al. [34], who reported that the
effect of 10 weeks of resistance or aerobic exercise training
on alterations of total body fat mass (TB-FM), intra-abdomi-
nal fat mass (IA-FM), and total body lean mass (TB-LM). The
results showed that the aerobic group exhibited signiﬁcant
Table 3 Comparison of fat mass, muscle mass, cholesterol level, and triglycerides level between pre and post treatment in exercise and
control groups.
Pre treatment Post treatment MD % of change p-Value
x  SD x  SD
Exercise group Fat mass (%) 35.18 ± 3.45 31.83 ± 3.36 3.35 9.58 0.0001**
Muscle mass (%) 29.24 ± 3.48 32.22 ± 2.9 2.98 11 0.0001**
Cholesterol (mg/dl) 289.06 ± 15.79 262.2 ± 12.57 26.86 9.23 0.0001**
Triglycerides (mg/dl) 289.8 ± 10.37 261.66 ± 15.77 28.14 9.75 0.0001**
Control group Fat mass (%) 36.02 ± 3 36.41 ± 3.3 0.39 1.06 0.12*
Muscle mass (%) 28.64 ± 3.3 28.3 ± 2.92 0.34 1.01 0.15*
Cholesterol (mg/dl) 285.86 ± 16.42 289.86 ± 17.84 4 1.42 0.08*
Triglycerides (mg/dl) 285.93 ± 12.17 291 ± 11.38 5.07 1.81 0.02**
x: Mean, SD: Standard deviation, MD: Mean difference, p-value: Probability value.
** Signiﬁcant.
* Non signiﬁcant.
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signiﬁcant reductions in IA-FM (7.4%) and body mass
(1.1%). Compared with the aerobic and the control groups,
the resistance group signiﬁcantly (p< 0.05) improved TB-
FM (3.7%) and upper (46.3%) and lower (56.6%) body
strength.
Garcia et al. [35], who concluded that the exercise program
promoted signiﬁcant improvements in functional capacity.
These ﬁndings have positive implications for the control of
metabolic diseases, which are common in patients after liver
transplantation. Also, Kallwitz et al. [36] observed that, the
exercise intensity is inversely related to metabolic syndrome
after transplantation.
Ben Ounis et al. [37], they found that training intervention
increased lipid oxidation during exercise, improved the plasma
triglycerides and increased HDL-C. According to Johnson
et al. [20], who assessed the effect of aerobic exercise training
on blood lipids. Four weeks of aerobic cycling exercise, in
addition to the current physical activity guidelines, the results
was a signiﬁcantly reduced visceral adipose tissue volume by
12% (p< 0.01) and hepatic triglycerides concentration by
21% (p< 0.05) and a signiﬁcant (14%) reduction in plasma
free fatty acids (p< 0.05).
The impact of exercise training on the lipid proﬁle is vari-
able. The possible mechanisms that explain the improvement
in the lipid proﬁle include increased muscle and adipose tissue
PPARc and PGC-1amessenger RNA expression after physical
training, as demonstrated by Ruschke et al. [38]. Some studies
[39,40] have reported low-density lipoprotein cholesterol reduc-
tions after aerobic and resistance training. Another study dem-
onstrated a trend towards triglyceride level reductions after
resistance training only [41], whereas others did not ﬁnd any
change after aerobic, resistance, and combined training [42].
Exercise exerts an effect on HDL-C maturation and com-
position, cholesterol efﬂux, and cholesterol delivery to recep-
tors (reverse cholesterol transport). Positive effects of
exercise are also seen with blood triglycerides (TG), but little
speciﬁc effect is seen on low-density lipoprotein cholesterol
(LDL-C) and total cholesterol (TC) [43].
In conclusion, we found that, a combination of aerobic
exercise and resisted exercise had a signiﬁcant effect on sarco-
penic obesity (reduce fat mass and increase muscle mass) and
dyslipidemia (reduce cholesterol and triglyceride levels). For
this, a program of aerobic and resisted exercise training shouldform a core for most patients after liver transplantation aiming
to improve post transplantation health and survival, helping to
ensure that physical activity becomes a safe routine medical
treatment plan of patient management.
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